Scarica l'app Stockscreener
13.45
3.22%
0.42
Precedente Chiudi:
$13.03
Aprire:
$12.98
Volume 24 ore:
990.80K
Relative Volume:
0.58
Capitalizzazione di mercato:
$1.30B
Reddito:
-
Utile/perdita netta:
$-115.88M
Rapporto P/E:
-8.6954
EPS:
-1.5468
Flusso di cassa netto:
$-104.72M
1 W Prestazione:
+16.25%
1M Prestazione:
-49.11%
6M Prestazione:
-62.12%
1 anno Prestazione:
-14.06%
Intervallo 1D:
$12.61
$13.57
Intervallo di 1 settimana:
$11.28
$13.60
Portata 52W:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
13.45 | 1.30B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
New Leaf Venture Partners L.L.C. Has $27.51 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 9.4%Here's What Happened - MarketBeat
Norges Bank Acquires New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
(EWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Trexquant Investment LP Invests $2 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week LowHere's What Happened - MarketBeat
Vanguard Group Inc. Sells 49,214 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Leerink Partnrs Issues Optimistic Outlook for EWTX Earnings - MarketBeat
Schroder Investment Management Group Acquires Shares of 93,061 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Wedbush Reduces Earnings Estimates for Edgewise Therapeutics - MarketBeat
Cytokinetics rises as Edgewise posts mid-stage trial data for heart disorder therapy - MSN
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb - Yahoo Finance
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Orbimed Advisors Llc Purchases 496,771 Shares - MarketBeat
Cinctive Capital Management LP Cuts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Edgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
Edgewise Therapeutics (NASDAQ:EWTX) Price Target Cut to $52.00 by Analysts at Royal Bank of Canada - MarketBeat
Pictet Asset Management Holding SA Buys New Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics' (EWTX) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Investors Purchase High Volume of Put Options on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week LowHere's What Happened - MarketBeat
EWTX Stock Down 48% in a Week Despite Upbeat Cardiomyopathy Study Data - MSN
Friday’s Insider Activity: Top Execs Make Moves in Tech and Healthcare By Investing.com - Investing.com South Africa
Friday’s Insider Activity: Top Execs Make Moves in Tech and Healthcare - Investing.com
| MarketBeat - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Rating Lowered by Scotiabank - MarketBeat
Edgewise Therapeutics’ $200 Million Common Stock Offering - Global Legal Chronicle
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 7.3%Here's What Happened - MarketBeat
Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money - Insider Monkey
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock By Investing.com - Investing.com UK
Edgewise Therapeutics director Peter Thompson acquires $10 million in stock By Investing.com - Investing.com Australia
Edgewise Therapeutics director Peter Thompson acquires $10 million in stock - Investing.com India
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock - Investing.com
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):